Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A gene involved in certain types of intellectual disability regulates myelin sheath development

Published on: 03/02/2017 Reading time: 1 min
image
Retour à la recherche

Myelin, a protective sheath that covers various nerve fibers, is essential in the transmission of nerve signals and enables proper function of the nervous system. Myelin degeneration causes severe illnesses including multiple sclerosis. Lamia Bouslama-Oueghlani from the team led by Brahim Nait Oumesmar at Paris Brain Institute and collaborators proved that the Pak3 gene, involved in certain types of intellectual disabilities, regulates myelin sheath formation.

Myelin plays a critical role in nerve signal transfer as well as in axonal protection and support. It is necessary to ensure proper function of the nervous system, and myelin deficit is observed in severe pathologies including multiple sclerosis and leukodystrophy. Oligodendrocytes are the key cells in the development process.

Myelin and oligodendrocyte deficit is also described in several mental/psychiatric illnesses; recent studies highlighted the critical role played by myelin plasticity in cognitive and behavioral functions. Oligodendrocytes could therefore be targeted in neuropsychiatric pathologies including depression, autism and schizophrenia.

In this context, Pak3 is of particular interest. Several Pak3 genetic mutations were identified in mental illnesses with intellectual disability. PAK3 protein is expressed in the brain, where its action has mainly been studied in neurons but not in glial cells. However, Pak3 is expressed in oligodendrocytes and precursors, cells that are to become oligodendrocytes after differentiation and maturation.

For the first time, a research project involving the team led by Brahim Nait Oumesmar has focused on effects of a loss of function in gene Pak3 on oligodendrocyte and myelination development.

Researchers highlighted strong PAK3 protein expression in oligodendrocyte precursors, notably lowered in mature oligodendrocytes. The team found that loss of Pak3 function leads to poor differentiation of oligodendrocyte precursors and poor myelin sheath development is certain areas of the brain. However, it appears that in adults poor differentiation may be compensated by mature oligodendrocytes in terms of oligodendrocyte density as well as axon myelination.

Researchers also focused on the effects of lack of Pak3 at cellular level by comparing proliferation, migration and differentiation of oligodendrocyte precursor cultures with or without Pak3 expression. Results show that
PAK3 acts as a regulator of oligodendrocyte precursor differentiation.

The next step is studying how PAK3 acts on oligodendrocyte precursors, and understanding its involvement in mental and psychiatric illnesses.

Sources

https://pubmed.ncbi.nlm.nih.gov/27940202/
Maglorius Renkilaraj MR, Baudouin L, M Wells C, Doulazmi M, Wehrlé R, Cannaya V, Bachelin C, Barnier JV, Jia Z, Nait Oumesmar B, Dusart I, Bouslama-Oueghlani L.

Our news on the subject

TDAH : les troubles de l’attention sont associées à l’intrusion d’ondes du sommeil pendant l’éveil
ADHD: Attention difficulties are linked to the intrusion of sleep waves during wakefulness
Attention-deficit/hyperactivity disorder (ADHD) remains poorly understood from a biological perspective. An international study led by scientists from the Paris Brain Institute and Monash University in Australia suggests that some symptoms may be...
03.17.2026 Research, science & health
L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
See all our news